Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Miroslav Prucha

Showing results (11-20 of 15) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 15 results.
Antiviral Therapy|December 14, 2011
Valganciclovir prophylaxis against cytomegalovirus impairs lymphocyte proliferation and activation in renal transplant recipientsTomá Reischig, Miroslav Prucha, Lenka Sedlackova, et al.
Critical Care (London, England)|October 6, 2012
Blood levels of copeptin on admission predict outcomes in out-of-hospital cardiac arrest survivors treated with therapeutic hypothermiaPetr Ostadal, Andreas Kruger, Vladimira Zdrahalova, et al.
Shock (Augusta, Ga.)|June 18, 2004
Expression profiling: toward an application in sepsis diagnosticsMiroslav Prucha, Andriy Ruryk, Hinnerk Boriss, et al.
Clinical Therapeutics|October 1, 2019
Czech Hizentra Noninterventional Study With Rapid Push: Efficacy, Safety, Tolerability, and Convenience of Therapy With 20% Subcutaneous ImmunoglobulinTomas Milota, Marketa Bloomfield, Pavlina Kralickova, et al.
Leukemia Research|February 3, 2009
Molecular variability of FLT3/ITD mutants and their impact on the differentiation program of 32D cells: implications for the biological properties of AML blastsSona Pekova, Robert Ivanek, Michal Dvorak, et al.
Pageof 2

Showing results (11-20 of 15) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 15 results.
Antiviral Therapy|December 14, 2011
Valganciclovir prophylaxis against cytomegalovirus impairs lymphocyte proliferation and activation in renal transplant recipientsTomá Reischig, Miroslav Prucha, Lenka Sedlackova, et al.
Critical Care (London, England)|October 6, 2012
Blood levels of copeptin on admission predict outcomes in out-of-hospital cardiac arrest survivors treated with therapeutic hypothermiaPetr Ostadal, Andreas Kruger, Vladimira Zdrahalova, et al.
Shock (Augusta, Ga.)|June 18, 2004
Expression profiling: toward an application in sepsis diagnosticsMiroslav Prucha, Andriy Ruryk, Hinnerk Boriss, et al.
Clinical Therapeutics|October 1, 2019
Czech Hizentra Noninterventional Study With Rapid Push: Efficacy, Safety, Tolerability, and Convenience of Therapy With 20% Subcutaneous ImmunoglobulinTomas Milota, Marketa Bloomfield, Pavlina Kralickova, et al.
Leukemia Research|February 3, 2009
Molecular variability of FLT3/ITD mutants and their impact on the differentiation program of 32D cells: implications for the biological properties of AML blastsSona Pekova, Robert Ivanek, Michal Dvorak, et al.
Pageof 2